A mutation in protein phosphatase type 2A as a cause of melanoma progression

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1313-1319

  Ito, Akihiko ^a   Koma, Y I ^a   Watabe, K ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

B16 melanoma; Checkpoint; Genetic instability; Golgi complex; Migration; PP2A

Indexed keywords

B56GAMMA1 ISOFORM; HOLOENZYME; ISOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; UNCLASSIFIED DRUG;

CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL LINE; CELL NUCLEUS; CYTOPLASM; CYTOPLASM VESICLE; ENZYME ACTIVITY; GAMMA IRRADIATION; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; GOLGI COMPLEX; MELANOMA; METASTASIS; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; RNA TRANSCRIPTION;

ANIMALS; CELL CYCLE; GOLGI APPARATUS; MELANOMA, EXPERIMENTAL; MICE; MUTATION; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TRANSPORT;

EID: 0142031099     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Bershadsky A.D. and Futerman A.H. (1994). Disruption of the Golgi apparatus by brefeldin A blocks cell polarization and inhibits directed cell migration. Proc. Natl. Acad. Sci. USA 91, 5686-5689.
2. Bjalojan C., Ruegg J.C. and Takai A. (1988). Effects of okadaic acid on isometric tension and myosin phosphorylation of chemically skinned guinea-pig taenia coli. J. Physiol. 398, 81-95.
3. Cahill D.P., Kinzler K.W., Vogelstein B. and Lengauer C. (1999). Genetic instability and Darwinian selection in tumours. Trends. Cell Biol. 9, 57-60.
4. Chambers A.F. and Hill R.P. (1992). Tumor progression and metastasis. In: The Basic Science of Oncology. Tannock I.F. and Hill R.P. (eds). McGraw-Hill. New York. pp 219-239.
5. Chou C.F. and Omary M.B. (1994). Mitotic arrest with anti-microtubule agents or okadaic acid is associated with increased glycoprotein terminal GlcNAc's. J. Cell Sci. 107, 1833-1843.
6. Cohen P. (1991). Classification of protein-serine/threonine phosphatases: Identification and quantification in cell extracts. Methods Enzymol. 201, 389-398.
7. Dinter A. and Berger E.G. (1998). Golgi-disturbing agents. Histochem. Cell Biol. 109, 571-590.
8. Deichmann M., Thome M., Benner A., Egner U., Hartschuh W. and Naher H. (2002). PTEN/MMAC1 expression in melanoma resection specimens. Br. J. Cancer 87, 1431-1436.
9. Dobson S., Kar B., Kumar R., Adams B. and Barik S. (2001). A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, plasmodium falciparum. B.M.C. Microbiol. 1, 31.
10. Fidler I.J. (1975). Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218-224.
11. Goodman S.L., Vollmers H.P. and Birchmeier W. (1985). Control of cell locomotion: Perturbation with an antibody directed against specific glycoproteins. Cell 41, 1029-1038.
12. Hannus M., Feiguin F., Heisenberg C.P. and Eaton S. (2002). Planar cell polarization requires Widerborst, a B′ regulatory subunit of protein phosphatase 2A. Development 129, 3493-3503.
13. Hart I.R. (1979). The selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol. 97, 587-600.
14. Huang X., Cheng A. and Honkanen R.E. (1997). Genomic organization of the human PP4 gene encoding a serine/threonine protein phosphatase (PP4) suggests a common ancestry with PP2A. Genomics 44, 336-343.
15. Illidge T.M., Cragg M.S., Fringes B., Olive P. and Erenpreisa J.A. (2000). Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol. Int. 24, 621-633.
16. Ito A., Kataoka T.R., Watanabe M., Nishiyama K., Mazaki Y., Sabe H., Kitamura Y. and Nojima H. (2000a). A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO J. 19, 562-571.
17. Ito A., Katoh F., Kataoka T.R., Okada M., Tsubota N., Asada H., Yoshikawa K., Maeda S., Kitamura Y., Yamasaki H. and Nojima H. (2000b). A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest. 105, 1189-1197.
18. Ito A., Koma Y., Watabe K., Nagano T., Endo Y., Nojima H. and Kitamura Y. (2003a). A truncated isoform of the protein phosphatase 2A B56g regulatory subunit may promote genetic instability and cause tumor progression. Am. J. Pathol. 162, 81-91.
19. Ito A., Koma Y., Sohda M., Watabe K., Nagano T., Misumi Y., Nojima H. and Kitamura Y. (2003b). Localization of the PP2A B56g regulatory subunit at the golgi complex. Am. J. Pathol. 162, 479-489.
20. Johanna I., Whelan R.D.H., Watson R. and Parker P.J. (2002). PKCe controls the traffic of b1 integrins in motile cells. EMBO J. 21, 3608-3619.
21. Kamibayashi C., Estes R., Slaughter C. and Mumby M.C. (1991). Subunit interactions control protein phosphatase 2A: Effects of limited proteolysis, N-ethylmaleimide, and heparin on the interaction of the B subunit. J. Biol. Chem. 266, 13251-13260.
22. Kamibayashi C., Estes R., Lickteig R.L., Yang S.I., Craft C. and Mumby M.C. (1994). Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J. Biol. Chem. 269, 20139-20148.
23. Kataoka T.R., Ito A., Asada H., Watabe K., Nishiyama K., Nakamoto K., Itami S., Yoshikawa K., Ito M., Nojima H. and Kitamura Y. (2000). Annexin VII as a novel marker for invasive phenotype of malignant melanoma. Jpn. J. Cancer Res. 91, 75-83.
24. Kawabe T., Muslin A.J. and Korsmeyer S.J. (1997). HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature 385, 454-458.
25. Kinoshita N., Ohkura H. and Yanagida M. (1990). Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle. Cell 63, 405-415.
26. Kulkarni S.V., Gish G., Van Der Geer P., Henkemeyer M. and Pawson T. (2000). Role of p120 Ras-GAP in directed cell movement. J. Cell Biol. 149, 457-470.
27. Lengauer C., Kinzler K.W. and Vogelstein B. (1998). Genetic instabilities in human cancers. Nature 396, 643-649.
28. Li Q and Dang C.V. (1999). c-Myc overexpression uncouples DNA replication from mitosis. Mol. Cell Biol. 19, 5339-5351.
29. Lucocq J., Berger E. and Hug C. (1995). The pathway of Golgi cluster formation in okadaic acid-treated cells. J. Struct. Biol. 115, 318-330.
30. Millward T.A., Zolnierowicz S. and Hemmings B.A. (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24, 186-191.
31. Musch A., Cohen D., Kreitzer G. and Rodriguez-Boulan E. (2001). cdc42 regulates the exit of apical and basolateral proteins from the trans-Golgi network. EMBO J. 20, 2171-2179.
32. Nakagama H., Kaneko S., Shima H., Inamori H., Fukuda H., Kominami R., Sugimura T. and Nagao M. (1997). Induction of minisatellite mutation in NIH3T3 cells by treatment with the tumor promoter okadaic acid. Proc. Natl. Acad. Sci. USA 94, 10813-10816.
33. Nakaji T., Kataoka T.R., Watabe K., Nishiyama K., Nojima H., Shimada Y., Sato F., Matsushima H., Endo Y., Kuroda Y., Kitamura Y., Ito A. and Maeda S. (1999). A new member of the GTPase superfamily that is upregulated in highly metastatic cells. Cancer Lett. 147, 139-147
34. Nakamoto K., Ito A., Watabe K., Koma Y., Asada H., Yoshikawa K., Shinomura Y., Matsuzawa Y., Nojima H. and Kitamura Y. (2001). Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: Evidence for its role in nucleolar sizing and function. Am. J. Pathol. 159, 1363-1374.
35. Ng T., Shima D., Squire A., Bastiaens P.I., Gschmeissner S., Humphries M.J. and Parker P.J. (1999). PKCa regulates β1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 18, 3909-3923.
36. Norman J.C., Jones D., Barry S.T., Holt M.R., Cockroft S. and Critchley D.R. (1998). ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J. Cell Biol. 143, 1981-1995.
37. Nowell P.C. (1976). The clonal evolution of tumor cell populations. Science 194, 23-28.
38. Okamoto K., Li H., Jensen R.M., Zhang T., Taya Y., Thorgeirsson S.S. and Prives C. (2002). Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol. Cell 9, 761-771.
39. Paulovich A.G., Toczyski D.P. and Hartwell L.H. (1997). When checkpoints fail. Cell 88, 315-321.
40. Poste G., Doll J., Hart I.R. and Fidler I.J. (1980). In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40, 1636-1644.
41. Shapiro J.R., Yung W.K. and Shapiro W.R. (1981). Isolation, karyotype, and clonal growth of heterogenous subpopulations of human malignant gliomas. Cancer Res. 41, 2349-2359.
42. Sherr C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
43. Takai A., Bialojan C., Troschka M. and Ruegg J.C. (1987). Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin. FEBS Lett. 217, 81-84.
44. Thyberg J. and Moskalewski S. (1992). Disorganization of the Golgi complex and the cytoplasmic microtubule system in CHO cells exposed to okadaic acid. J. Cell Sci. 103, 1167-1175.
45. Usui H., Imazu M., Maeta K., Tsukamoto H., Azuma K. and Takeda M. (1988). Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J. Biol. Chem. 263, 3752-3761.
46. Van Lookeren Campagne M., Okamoto K., Prives C. and Gill R. (1999). Developmental expression and co-localization of cyclin G1 and the B′ subunits of protein phosphatase 2a in neurons. Brain Res. Mol. Brain Res. 64, 1-10.
47. Virshup D.M. (2000). Protein phosphatase 2A: A panoply of enzymes. Curr. Opin. Cell Biol. 12, 180-185.
48. Waldman T., Lengauer C., Kinzler K.W. and Vogelstein B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
49. Watabe K., Ito A., Asada H., Endo Y., Kobayashi T., Nakamoto K., Itami S., Takao S., Shinomura Y., Aikou T., Yoshikawa K., Matsuzawa Y., Kitamura Y. and Nojima H. (2001). Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells. Jpn. J. Cancer Res. 92, 140-151.
50. Yamashita K., Yasuda H., Pines J., Yasumoto K., Nishitani H., Ohtsubo M., Hunter T., Sugimura T. and Nishimoto T. (1990). Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J. 9, 4331-4338.